REFERENCES
1. Hiratzka LF, Eastham CL, Carter JG, et al. The effects of cardiopulmonary bypass and cold cardioplegia on coronary flow velocity and the reactive hyperemic response in patients and dogs. Ann Thorac Surg 1988;45:474-81.
2. De Backer D, Dubois MJ, Schmartz D, et al. Microcirculatory alterations in cardiac surgery: effects of cardiopulmonary bypass and anesthesia. Ann Thorac Surg 2009;88:1396-403.
3. Sellke N, Kuczmarski A, Lawandy I, et al. Enhanced coronary arteriolar contraction to vasopressin in patients with diabetes after cardiac surgery. J Thorac Cardiovasc Surg 2018;156:2098-107.
4. Sellke N, Gordon C, Lawandy I, et al. Impaired coronary contraction to phenylephrine after cardioplegic arrest in diabetic patients. J Surg Res 2018;230:80-6.
5. Feng J, Chu LM, Robich MP, et al. Effects of cardiopulmonary bypass on endothelin-1-induced contraction and signaling in human skeletal muscle microcirculation. Circulation 2010;122:S150-5.
6. Sodha NR, Feng J, Clements RT, et al. Protein kinase C alpha modulates microvascular reactivity in the human coronary and skeletal microcirculation. Surgery 2007;142:243-52.
7. Feng J, Liu Y, Chu LM, et al. Thromboxane-induced contractile response of human coronary arterioles is diminished after cardioplegic arrest. Ann Thorac Surg 2011;92:829-36.
8. Murkin JM. Monitoring and optimization of the microcirculation during CPB. J Thorac Dis 2019;11:S1489-91.
9. Os MM, van den Brom CE, van Leeuwen ALI, Dekker NAM. Microcirculatory perfusion disturbances following cardiopulmonary bypass: a systematic review. Crit Care 2020;24:218.
10. Ruel M, Khan TA, Voisine P, Bianchi C, Sellke FW. Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg 2004;26:1002-14.
11. Jackson WF. Ion channels and the regulation of myogenic tone in peripheral arterioles. Ion Channels and Calcium Signaling in the Microcirculation. Curr Top Membr 2020;85:19-58.
12. Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol 2007;292:H2613-22.
13. Schubert R, Brayden JE. . Stretch-activated Cation Channels and the Myogenic Response of Small Arteries. In: Kamkin A, Kiseleva I, editors. Mechanosensitivity in Cells and Tissues. Moscow: Academia; 2005.
14. Dessy C, Matsuda N, Hulvershorn J, Sougnez CL, Sellke FW, Morgan KG. Evidence for involvement of the PKC-alpha isoform in myogenic contractions of the coronary microcirculation. Am J Physiol Heart Circ Physiol 2000;279:H916-23.
15. Jensen LJ, Nielsen MS, Salomonsson M, Sørensen CM. T-type Ca2+ channels and autoregulation of local blood flow. Channels (Austin) 2017;11:183-95.
16. Amin AH, Abd Elmageed ZY, Partyka M, Matrougui K. Mechanisms of myogenic tone of coronary arteriole: Role of down stream signaling of the EGFR tyrosine kinase. Microvasc Res 2011;81:135-42.
17. Lucchesi PA, Sabri A, Belmadani S, Matrougui K. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 2004;110:3587-93.
18. Cipolla MJ, Gokina NI, Osol G. Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 2002;16:72-6.
19. Davis MJ, Wu X, Nurkiewicz TR, et al. Integrins and mechanotransduction of the vascular myogenic response. Am J Physiol Heart Circ Physiol 2001;280:H1427-33.
20. Wang SY, Friedman M, Franklin A, Sellke FW. Myogenic reactivity of coronary resistance arteries after cardiopulmonary bypass and hyperkalemic cardioplegia. Circulation 1995;92:1590-6.
21. Wang SY, Stamler A, Li J, Johnson RG, Sellke FW. Decreased myogenic reactivity in skeletal muscle arterioles after hypothermic cardiopulmonary bypass. J Surg Res 1997;69:40-4.
22. Khan TA, Bianchi C, Ruel M, et al. Mitogen-activated protein kinase inhibition and cardioplegia-cardiopulmonary bypass reduce coronary myogenic tone. Circulation 2003;108 Suppl 1:II348-53.
23. Feng J, Liu Y, Khabbaz KR, et al. Large conductance calcium-activated potassium channels contribute to the reduced myogenic tone of peripheral microvasculature after cardiopulmonary bypass. J Surg Res 2009;157:123-8.
24. Tofukuji M, Stamler A, Li J, Hariawala MD, Franklin A, Sellke FW. Comparative effects of continuous warm blood and intermittent cold blood cardioplegia on coronary reactivity. Ann Thorac Surg 1997;64:1360-7.
25. Wang SY, Stamler A, Tofukuji M, Deuson TE, Sellke FW. Effects of blood and crystalloid cardioplegia on adrenergic and myogenic vascular mechanisms. Ann Thorac Surg 1997;63:41-9.
26. Banitt PF, Dai HB, Wang SY, Friedman M, Sellke FW. Myogenic and agonist induced responses of coronary venules after cold hyperkalaemic cardioplegia. Cardiovasc Res 1995;29:827-33.
27. Hattori Y, Kakishita H, Akimoto K, Matsumura M, Kasai K. Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C. Biochem Biophys Res Commun 2001;281:891-6.
28. Velarde V, Jenkins AJ, Christopher J, Lyons TJ, Jaffa AA. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J Appl Physiol (1985) 2001;91:1412-20.
29. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, Gutterman DD. Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res 2002;91:1070-6.
30. Nardi P, Pisano C, Bertoldo F, et al. Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery. Cell Death Discov 2018;4:23.
31. Feng J, Sellke F. Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass. Curr Opin Cardiol 2016;31:618-24.
32. Pires PW, Jackson WF, Dorrance AM. Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor. Am J Physiol Heart Circ Physiol 2015;309:H127-36.
33. Brummelen P, Jie K, van Zwieten PA. Alpha-adrenergic receptors in human blood vessels. Br J Clin Pharmacol 1986;21 Suppl 1:33S-9S.
34. Wang SY, Friedman M, Johnson RG, Weintraub RM, Sellke FW. Adrenergic regulation of coronary microcirculation after extracorporeal circulation and crystalloid cardioplegia. Am J Physiol 1994;267:H2462-70.
35. Lundvall J, Järhult J. Beta adrenergic dilator component of the sympathetic vascular response in skeletal muscle. Influence on the micro-circulation and on transcapillary exchange. Acta Physiol Scand 1976;96:180-92.
36. Ziegler O, Anderson K, Liu Y, et al. Skeletal muscle microvasculature response to β-adrenergic stimuli is diminished with cardiac surgery. Surgery 2020;167:493-8.
37. Tan CMJ, Green P, Tapoulal N, Lewandowski AJ, Leeson P, Herring N. The role of neuropeptide Y in cardiovascular health and disease. Front Physiol 2018;9:1281.
39. Silva AP, Cavadas C, Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clinica Chimica Acta 2002;326:3-25.
40. Mirman B, Ikeda I, Zhang Z, et al. Effects of neuropeptide Y on the microvasculature of human skeletal muscle. Surgery 2020;168:155-9.
41. Matyal R, Mahmood F, Robich M, et al. Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue. Eur J Pharmacol 2011;665:19-28.
42. Meng F, Han J, Wang J, Zhang H, Xu C, Meng X. The gender-specific expression of neuropeptide Y and neuropeptide Y receptors in human atrial tissue during cardiopulmonary bypass surgery. J Thorac Dis 2018;10:6563-8.
43. Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem 2006;13:1655-65.
44. Kowalczyk A, Kleniewska P, Kolodziejczyk M, Skibska B, Goraca A. The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis. Arch Immunol Ther Exp (Warsz) 2015;63:41-52.
45. Bond BR, Dorman BH, Clair MJ, et al. Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg 2001;122:358-64.
46. Verma S, Maitland A, Weisel RD, et al. Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: reversal by means of endothelin antagonism. J Thorac Cardiovasc Surg 2002;123:1114-9.
47. Feng J, Liu Y, Khabbaz KR, et al. Endothelin-1-induced contractile responses of human coronary arterioles via endothelin-A receptors and PKC-alpha signaling pathways. Surgery 2010;147:798-804.
48. Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacol Rev 2012;64:359-88.
49. Berg KA, Clarke WP. Regulation of 5-HT1A and 5-HT1B receptor systems by phospholipid signaling cascades. Brain Res Bull 2001;56:471-7.
50. Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 2001;167:2831-8.
51. Sabe SA, Feng J, Liu Y, Scrimgeour LA, Ehsan A, Sellke FW. Decreased contractile response of peripheral arterioles to serotonin after CPB in patients with diabetes. Surgery 2018;164:288-93.
52. Metais C, Li J, Simons M, Sellke FW. Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion: role of COX-2 expression. Circulation 1999;100:II328-34.
53. Metais C, Bianchi C, Li J, Simons M, Sellke FW. Serotonin-induced human coronary microvascular contraction during acute myocardial ischemia is blocked by COX-2 inhibition. Basic Res Cardiol 2001;96:59-67.
54. Robich MP, Araujo EG, Feng J, et al. Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass. J Thorac Cardiovasc Surg 2010;139:1033-40.
55. Sato K, Li J, Metais C, Bianchi C, Sellke F. Increased pulmonary vascular contraction to serotonin after cardiopulmonary bypass: role of cyclooxygenase. J Surg Res 2000;90:138-43.
56. Masetti P, Murphy SF, Kouchoukos NT. Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass. J Card Surg 2002;17:485-9.
57. Holmes CL, Landry DW, Granton JT. Science review: Vasopressin and the cardiovascular system part 1--receptor physiology. Crit Care 2003;7:427-34.
58. Khan TA, Bianchi C, Ruel M, Feng J, Sellke FW. Differential effects on the mesenteric microcirculatory response to vasopressin and phenylephrine after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2007;133:682-8.
59. Sellke FW, Friedman M, Dai HB, Shafique T, Schoen FJ, Weintraub RM, Johnson RG. Mechanisms causing coronary microvascular dysfunction following crystalloid cardioplegia and reperfusion. Cardiovasc Res 1993;27:1925-32.
60. Nakahata N. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 2008;118:18-35.
61. Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 2005;1:183-98.
62. He GW. Coronary endothelial function in open heart surgery. Clin Exp Pharmacol Physiol 1997;24:955-7.
63. Sellke FW, Shafique T, Ely DL, Weintraub RM. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals. Circulation 1993;88:II395-400.
64. Sellke FW, Shafique T, Schoen FJ, Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg 1993;105:52-8.
65. Sellke FW, Shafique T, Johnson RG, Dai HB, Banitt PF, Schoen FJ, Weintraub RM. Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg 1993;55:977-85.
66. Feng J, Sellke ME, Ramlawi B, et al. Bradykinin induces microvascular preconditioning through the opening of calcium-activated potassium channels. Surgery 2006;140:192-7.
67. Feng J, Bianchi C, Li J, Sellke FW. Improved profile of bad phosphorylation and caspase 3 activation after blood versus crystalloid cardioplegia. Ann Thorac Surg 2004;77:1384-9; discussion 1389.
68. Feng J, Bianchi C, Sandmeyer JL, Sellke FW. Bradykinin preconditioning improves the profile of cell survival proteins and limits apoptosis after cardioplegic arrest. Circulation 2005;112:I190-5.
69. Feng J, Bianchi C, Li J, Sellke FW. Bradykinin preconditioning preserves coronary microvascular reactivity during cardioplegia-reperfusion. Ann Thorac Surg 2005;79:911-6.
70. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-44.
71. Aljure OD, Fabbro M 2nd. Cardiopulmonary bypass and inflammation: the hidden enemy. J Cardiothorac Vasc Anesth 2019;33:346-7.
72. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:S715-20.
73. Lambert J, Aarsen M, Donker AJ, Stehouwer CD. Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:705-11.
74. Chen K, Pittman RN, Popel AS. Nitric oxide in the vasculature: where does it come from and where does it go? Antioxid Redox Signal 2008;10:1185-98.
75. Engelman DT, Watanabe M, Engelman RM, et al. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 1995;110:1047-53.
76. He G, Yang C. Hyperkalemia alters endothelium-dependent relaxation through non-nitric oxide and noncyclooxygenase pathway: a mechanism for coronary dysfunction due to cardioplegia. Ann Thorac Surg 1996;61:1394-9.
77. Andrási TB, Soós P, Bakos G, et al. L-arginine protects the mesenteric vascular circulation against cardiopulmonary bypass-induced vascular dysfunction. Surgery 2003;134:72-9.
78. Meldrum DR, Cleveland JC, Sheridan BC, Rowland RT, Banerjee A, Harken AH. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg 1996;61:1273-80.
79. Mehlhorn U, Bloch W. Role of cardiopulmonary bypass and cardioplegic arrest in the regulation of cardiac nitric oxide synthase activity. J Thorac Cardiovasc Surg 2002;124:418-9.
80. Kukreja RC, Hess ML. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992;26:641-55.
81. Sellke FW, Boyle EM, Verrier ED. Endothelial cell injury in cardiovascular surgery: The pathophysiology of vasomotor dysfunction. Ann Thorac Surg 1996;62:1222-8.
82. Stahl GL, Reenstra WR, Frendl G. Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex. Circ Res 1995;76:575-83.
83. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl 1997;49:15-9.
84. Matsumoto H, Naraba H, Murakami M, et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem Biophys Res Commun 1997;230:110-4.
85. Brock TG, McNish RW, Peters-Golden M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem 1999;274:11660-6.
86. Ricciotti E, Yu Y, Grosser T, Fitzgerald GA. COX-2, the dominant source of prostacyclin. Proc Natl Acad Sci U S A 2013;110:E183.
87. Sodha NR, Clements RT, Sellke FW. Vascular changes after cardiac surgery: role of NOS, COX, kinases, and growth factors. Front Biosci (Landmark Ed) 2009;14:689-98.
88. Sellke FW. Vascular changes after cardiopulmonary bypass and ischemic cardiac arrest: roles of nitric oxide synthase and cyclooxygenase. Braz J Med Biol Res 1999;32:1345-52.
89. Feng J, Anderson K, Singh AK, et al. Diabetes upregulation of cyclooxygenase 2 contributes to altered coronary reactivity after cardiac surgery. Ann Thorac Surg 2017;104:568-76.
90. Garland CJ, Yarova PL, Jiménez-Altayó F, Dora KA. Vascular hyperpolarization to β-adrenoceptor agonists evokes spreading dilatation in rat isolated mesenteric arteries. Br J Pharmacol 2011;164:913-21.
91. Liu Y, Xie A, Singh AK, et al. Inactivation of endothelial small/intermediate conductance of calcium-activated potassium channels contributes to coronary arteriolar dysfunction in diabetic patients. J Am Heart Assoc 2015;4:e002062.
92. Liu Y, Kabakov AY, Xie A, et al. Metabolic regulation of endothelial SK channels and human coronary microvascular function. Int J Cardiol 2020;312:1-9.
93. Xing H, Zhang Z, Shi G, et al. Chronic inhibition of mROS protects against coronary endothelial dysfunction in mice with diabetes. Front Cell Dev Biol 2021;9:643810.
94. Si H, Heyken WT, Wölfle SE, et al. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 2006;99:537-44.
95. Liu Y, Sellke EW, Feng J, et al. Calcium-activated potassium channels contribute to human skeletal muscle microvascular endothelial dysfunction related to cardiopulmonary bypass. Surgery 2008;144:239-44.
96. Feng J, Liu Y, Clements RT, et al. Calcium-activated potassium channels contribute to human coronary microvascular dysfunction after cardioplegic arrest. Circulation 2008;118:S46-51.
97. Liu Y, Cole V, Lawandy I, Ehsan A, Sellke FW, Feng J. Decreased coronary arteriolar response to KCa channel opener after cardioplegic arrest in diabetic patients. Mol Cell Biochem 2018;445:187-94.
98. Zhang Z, Shi G, Liu Y, et al. Coronary endothelial dysfunction prevented by small-conductance calcium-activated potassium channel activator in mice and patients with diabetes. J Thorac Cardiovasc Surg 2020;160:e263-80.
99. Yang Q, Huang JH, Man YB, Yao XQ, He GW. Use of intermediate/small conductance calcium-activated potassium-channel activator for endothelial protection. J Thorac Cardiovasc Surg 2011;141:501-10, 510.e1.
100. Yang Q, Underwood MJ, He GW. Calcium-activated potassium channels in vasculature in response to ischemia-reperfusion. J Cardiovasc Pharmacol 2012;59:109-15.
101. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981;304:497-503.
102. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8.
103. Pinckard RN, Olson MS, Giclas PC, Terry R, Boyer JT, O'Rourke RA. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest 1975;56:740-50.
104. Tofukuji M, Stahl GL, Metais C, et al. Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a. Ann Thorac Surg 2000;69:799-807.
105. Park KW, Tofukuji M, Metais C, et al. Attenuation of endothelium-dependent dilation of pig pulmonary arterioles after cardiopulmonary bypass is prevented by monoclonal antibody to complement C5a. Anesth Analg 1999;89:42-8.
106. Tofukuji M, Stahl GL, Agah A, Metais C, Simons M, Sellke FW. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction. J Thorac Cardiovasc Surg 1998;116:1060-8.
107. Tofukuji M, Metais C, Collard CD, et al. Effect of sialyl Lewisx oligosaccharide on myocardial and cerebral injury in the pig. Ann Thorac Surg 1999;67:112-9.
108. Kawata H, Sawatari K, Mayer JE, Jr. . Evidence for the role of neutrophils in reperfusion injury after cold cardioplegic ischemia in neonatal lambs. J Thorac Cardiovasc Surg. 1992;103:908-17; discussion 17-8.
109. Schermerhorn ML, Tofukuji M, Khoury PR, et al. Sialyl lewis oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs. J Thorac Cardiovasc Surg 2000;120:230-7.
110. Giacinto O, Satriano U, Nenna A, et al. Inflammatory response and endothelial dysfunction following cardiopulmonary bypass: pathophysiology and pharmacological targets. Recent Pat Inflamm Allergy Drug Discov 2019;13:158-73.
111. Tofukuji M, Metais C, Li J, Franklin A, Simons M, Sellke FW. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia. Circulation 1998;98:II242-6; discussion II7.
112. Emani S, Ramlawi B, Sodha NR, Li J, Bianchi C, Sellke FW. Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor. J Thorac Cardiovasc Surg 2009;138:185-91.
113. Mieno S, Ramlawi B, Boodhwani M, et al. Role of stromal-derived factor-1alpha in the induction of circulating CD34+CXCR4+ progenitor cells after cardiac surgery. Circulation 2006;114:I186-92.
114. Bianchi C, Araujo EG, Sato K, Sellke FW. Biochemical and structural evidence for pig myocardium adherens junction disruption by cardiopulmonary bypass. Circulation 2001;104:I319-24.
115. Khan TA, Bianchi C, Araujo E, et al. Aprotinin preserves cellular junctions and reduces myocardial edema after regional ischemia and cardioplegic arrest. Circulation 2005;112:I196-201.
116. Feng J, Liu Y, Sabe AA, et al. Differential impairment of adherens-junction expression/phosphorylation after cardioplegia in diabetic versus non-diabetic patients. Eur J Cardiothorac Surg 2016;49:937-43.
117. Feng J, Liu Y, Singh AK, et al. Effects of diabetes and cardiopulmonary bypass on expression of adherens junction proteins in human peripheral tissue. Surgery 2017;161:823-9.
118. Hinsbergh VW, van Nieuw Amerongen GP. Endothelial hyperpermeability in vascular leakage. Vascul Pharmacol 2002;39:171-2.
119. Clajus C, Lukasz A, David S, et al. Angiopoietin-2 is a potential mediator of endothelial barrier dysfunction following cardiopulmonary bypass. Cytokine 2012;60:352-9.
120. Feng J, Liu Y, Chu LM, et al. Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes. Circulation 2012;126:S73-80.
121. Feng J, Chu LM, Dobrilovic N, Liu Y, Singh AK, Sellke FW. Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus. Surgery 2012;152:262-9.
123. Feng J, Anderson K, Liu Y, Singh AK, Ehsan A, Sellke FW. Cyclooxygenase 2 contributes to bradykinin-induced microvascular responses in peripheral arterioles after cardiopulmonary bypass. J Surg Res 2017;218:246-52.
124. Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 2010;12:448-55.
